Your browser doesn't support javascript.
loading
A double-blind, placebo-controlled, single-ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of HM15136, a novel long-acting glucagon analogue, in healthy subjects.
Huh, Ki Young; Hwang, Jun Gi; Shin, Wonjung; Baek, Seungjae; Choi, JaeDuk; Lee, Nora; Cho, Young Min; Lee, Howard.
Afiliação
  • Huh KY; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Hwang JG; Department of Clinical Pharmacology and Therapeutics, Chungbuk National University Hospital, Cheongju-si, South Korea.
  • Shin W; Hanmi Pharmaceutical Co., Ltd, Seoul, South Korea.
  • Baek S; Hanmi Pharmaceutical Co., Ltd, Seoul, South Korea.
  • Choi J; Hanmi Pharmaceutical Co., Ltd, Seoul, South Korea.
  • Lee N; Hanmi Pharmaceutical Co., Ltd, Seoul, South Korea.
  • Cho YM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
  • Lee H; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
Diabetes Obes Metab ; 24(3): 411-420, 2022 03.
Article em En | MEDLINE | ID: mdl-34726329
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glucagon / Insulina Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glucagon / Insulina Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul País de publicação: Reino Unido